The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females

The Journal of Clinical Endocrinology and Metabolism
E J SchaeferR I Levy

Abstract

The effects of estrogen administration (ethinyl estradiol; 0.1 mg, orally, daily) on plasma lipoprotein metabolism were investigated in five normolipidemic premenopausal females. Estrogen administration resulted in significant (P less than 0.05) mean increases in plasma cholesterol, triglyceride, very low density lipoprotein (VLDL)-cholesterol, and high density lipoprotein (HDL)-cholesterol of 18.8%, 87.0%, 123.1%, and 38.3%, respectively. Analytical ultracentrifugation demonstrated that HDL increases occurred mainly in the HDL2b subfraction (150.0% increase). Lipoprotein compositional analysis showed that estrogen administration caused significant increases in all VLDL and HDL constituents (protein, cholesterol, phospholipid, and triglyceride) as well as VLDL apolipoprotein (apo) B (118.9% increase) and HDL apoA-I (27.4% increase). No significant changes in LDL constituents were noted. Measurement of lipoprotein lipase and hepatic lipase enzymic activity in post-heparin plasma revealed no major change in lipoprotein lipase activity, but showed a significant decrease (43.8%) in hepatic lipase activity during estrogen administration. Radioiodinated VLDL and HDL kinetic data indicated increased VLDL apoB (86.1% rise) and HDL apoA...Continue Reading

Citations

Aug 1, 1990·Clinical Cardiology·R F Leighton
Feb 1, 1990·Molecular Reproduction and Development·E EhrenwaldJ E Parks
Sep 1, 1993·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·C MassafraG Colombini
May 8, 1991·Biochimica Et Biophysica Acta·N EmmisonL Agius
Sep 1, 1995·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·J Shepherd
Sep 1, 1991·Atherosclerosis·M Seed
Jan 4, 1993·Atherosclerosis·J C StevensonI F Godsland
Feb 1, 1994·Atherosclerosis·P M Lyons WallA S Truswell
Apr 1, 1987·Journal of Steroid Biochemistry·K B Marschke, D R Koritnik
Feb 1, 1986·Metabolism: Clinical and Experimental·M J TikkanenU H Stenman
Nov 1, 1986·European Journal of Obstetrics, Gynecology, and Reproductive Biology·K De CleynJ Gerris
Jun 16, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·W Piechota, A Staszewski
Jan 1, 1994·Pharmacology & Therapeutics·G FranceschiniL Calabresi
Oct 1, 1994·Pharmacology & Therapeutics·J A Gevers Leuven
Nov 1, 1992·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·L E PerezI P Callard
May 1, 1996·Maturitas·M J Tikkanen
Jun 12, 2003·Metabolism: Clinical and Experimental·Patty W Siri, Henry N Ginsberg
Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·D Crook, M Seed
Jan 1, 1993·Baillière's Clinical Endocrinology and Metabolism·H H Newnham

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.